Clinical trial Recruiting at 1 site Interventional Ages 12 to 21

Effects of brain stimulation on adolescents with autism

Official title: Cumulative and Booster Effects of Multisession Prefrontal Transcranial Direct-Current Stimulation (tDCS) on Cognitive and Social Impairments in Adolescents With Autism Spectrum Disorder

Run by The Hong Kong Polytechnic University · NCT05492032 · Data updated 2026-11-12

This study is testing if a type of brain stimulation combined with cognitive training can help improve anxiety, aggression, and social communication in adolescents with autism.

Quick facts

Study typeInterventional
Ages12 Years to 21 Years
SexAll
Enrollment150 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations1 site (Hung Hom, Kowloon)
StatusRecruiting
StartedJune 2, 2022
Main results expectedSeptember 30, 2027
Study endsSeptember 30, 2027
Registry record updatedNovember 10, 2026
Trial IDNCT05492032 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adolescents diagnosed with autism spectrum disorder, particularly those who may also exhibit symptoms of ADHD.

Probably not a fit

Patients without a confirmed diagnosis of autism or those with other neurological disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the cumulative and booster effects of multisession prefrontal transcranial direct current stimulation (tDCS) on adolescents diagnosed with autism spectrum disorder (ASD). The approach involves applying active and sham tDCS alongside cognitive training to assess its impact on core symptoms such as anxiety, aggression, and social communication difficulties. Participants will be carefully selected based on established diagnostic criteria and monitored for any changes in their condition throughout the treatment period.

Why it matters

Potential benefit: If successful, this intervention could significantly improve social communication and reduce behavioral issues in adolescents with autism.

How similar studies have gone: Previous studies have shown promise in using tDCS for treating symptoms of autism, indicating potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Individuals who are confirmed by a clinical psychologist based on the Diagnostic and Statistical Manual of Mental Disorders-5th Ed (DSM-V) criteria of Autism spectrum disorder and structured interview with their parents or primary caregivers on their developmental history using the Autism Diagnostic Interview-Revised (ADI-R).
* Individuals with ASD who are comorbid with ADHD symptoms will be included if they were willing to abstain from the use of these medications at least 96 hours before the commencement, until the completion, of the treatment.
* In view of the fact that neuroadaptation to antipsychotics typically occurs within six months, potential participants who are prescribed antipsychotic medications will only be included if the dosage of the medication remained unchanged for six months or more before the experimental period.

Exclusion Criteria:

* Individuals without a confirmed diagnosis from the clinical psychologist, with a history of other neurological and psychiatric disorders and head trauma, or on psychiatric medication will be excluded from the study.
* In view of the possibility of seizure induction by tDCS, potential ASD participants comorbid with epilepsy will be excluded.
* Potential participants comorbid with mood or anxiety disorders will also be excluded.

Where it's running

  • The Hong Kong Polytechnic University
    Hung Hom, Kowloon, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.